1 / 6

COGNISION ™ for Non-invasive Screening of Alzheimer’s Disease

COGNISION ™ for Non-invasive Screening of Alzheimer’s Disease. IDND Presentation Sept 25, 2007. How is AD Currently Diagnosed?. No FDA approved diagnostic modalities for Alzheimer’s disease Definitive diagnosis is currently made only after death Current diagnostic methods include:

naomi
Download Presentation

COGNISION ™ for Non-invasive Screening of Alzheimer’s Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. COGNISION™forNon-invasive ScreeningofAlzheimer’s Disease IDND Presentation Sept 25, 2007

  2. How is AD Currently Diagnosed? • No FDA approved diagnostic modalities for Alzheimer’s disease • Definitive diagnosis is currently made only after death • Current diagnostic methods include: • Neuropsychological Testing • Not practical • Cerebral Spinal Fluid Analysis • Invasive • Positron Emission Tomography (PET) • Expensive • “Probable AD” diagnosis only made in half of persons affected1 • Applied Neurology, Alzheimer Disease: Diagnosis and Treatment Across the Spectrum (Nov 2005)

  3. Event-Related Potentials Conceptually Simple Complex in Practice

  4. COGNISION™ ERP System • Practical • Non-invasive • Inexpensive • Easy-to-Use • Effective • Validated Protocols • Centralized Database • Automated Analysis • Viable Business • Charge per Test

  5. COGNISION™ Network

  6. Clinical Studies Phase 1 Study Set for Fall 2007 • PI: • UK – Smith (Sanders Brown Center for Aging) • Goal: • Validate system function • Endpoint: • Complete ERP tests in all subjects Phase 2 Study • Training Phase: • NIH Centers of Excellence for Alzheimer’s Disease • ADNI protocol • Clinical Phase: • IDND, Jewish Hospital (Louisville) • COGNISION™ protocol only • Endpoint 1: • Perform COGNISION™ System training • Endpoint 2: • Test classifiers in clinical (not research) settings

More Related